HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoming Huang Selected Research

Neoplasms (Cancer)

2/2024Orchestrating Precision within the Tumor Microenvironment by Biomimetic Nanoprodrugs for Effective Tumor Therapy.
1/2024MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma.
1/2024The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside.
12/2023Tislelizumab plus chemotherapy as first-line treatment for recurrent or metastatic nasopharyngeal cancer: A multicenter phase 3 trial (RATIONALE-309).
11/2023Targeting Src reactivates pyroptosis to reverse chemoresistance in lung and pancreatic cancer models.
10/2023Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling.
9/2023C2orf48 promotes the progression of nasopharyngeal carcinoma by regulating high mobility group AT-hook 2.
9/2023Identification of a distinct tumor endothelial cell-related gene expression signature associated with patient prognosis and immunotherapy response in multiple cancers.
4/2023Bioinformatics analysis based on DNA methylation data identified in lung adenocarcinoma subgroups with different immune characteristics and clinical outcomes.
11/2022Upregulated YTHDF1 associates with tumor immune microenvironment in head and neck squamous cell carcinomas.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoming Huang Research Topics

Disease

36Neoplasms (Cancer)
02/2024 - 01/2009
9Squamous Cell Carcinoma of Head and Neck
04/2024 - 01/2017
7Carcinoma (Carcinomatosis)
11/2023 - 07/2013
6Neoplasm Metastasis (Metastasis)
04/2024 - 07/2013
6Glioma (Gliomas)
01/2024 - 01/2019
6Hemorrhage
01/2021 - 09/2002
5Cicatrix (Scar)
10/2023 - 10/2011
5Nasopharyngeal Carcinoma
01/2021 - 10/2006
4Lung Neoplasms (Lung Cancer)
11/2023 - 02/2020
4Infections
10/2023 - 03/2016
3Postoperative Hemorrhage
08/2023 - 01/2019
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 02/2020
3Branchioma (Branchial Cleft Cysts)
12/2014 - 05/2012
2Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
04/2024 - 12/2023
2Triple Negative Breast Neoplasms
01/2024 - 05/2021
2Lymphatic Metastasis
08/2023 - 01/2021
2Frailty
01/2023 - 11/2022
2Fatigue
03/2022 - 05/2021
2Fever (Fevers)
01/2022 - 10/2015
2Retinoblastoma (Glioblastoma, Retinal)
01/2022 - 01/2022
2Eagle syndrome
03/2021 - 07/2017
2Papillary Thyroid Cancer
01/2021 - 01/2021
2Rheumatoid Arthritis
01/2020 - 01/2019
2Arthritis (Polyarthritis)
01/2020 - 01/2019
2Carcinogenesis
01/2020 - 01/2019
2Prostatic Neoplasms (Prostate Cancer)
02/2019 - 02/2014
2Thyroglossal Cyst
01/2018 - 06/2014
1Neuroblastoma
04/2024
1Venous Thrombosis (Deep-Vein Thrombosis)
02/2024
1Exostoses
02/2024
1False Aneurysm (Pseudoaneurysm)
02/2024
1Genetic Predisposition to Disease (Genetic Predisposition)
11/2023
1Health Personnel Alert Fatigue
11/2023
1Hypokalemia
10/2023
1Opportunistic Infections (Opportunistic Infection)
10/2023
1Reinfection
10/2023
1Thyroid Diseases (Thyroid Disease)
10/2023
1Hyponatremia
10/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
10/2023
1Hypercalcemia (Milk Alkali Syndrome)
10/2023
1Acalculous Cholecystitis
09/2023
1Acute Abdomen
09/2023
1Rheumatic Diseases (Rheumatism)
09/2023
1Virus Diseases (Viral Diseases)
09/2023

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2018
6CytokinesIBA
10/2023 - 07/2013
5Proteins (Proteins, Gene)FDA Link
04/2024 - 02/2019
5MicroRNAs (MicroRNA)IBA
12/2020 - 07/2013
4tislelizumabIBA
04/2024 - 01/2020
3Messenger RNA (mRNA)IBA
05/2023 - 02/2019
3asphaltIBA
03/2022 - 04/2019
2Immune Checkpoint InhibitorsIBA
01/2024 - 11/2022
2LipidsIBA
11/2023 - 07/2019
2Glucose (Dextrose)FDA LinkGeneric
11/2023 - 01/2023
2Cetuximab (Erbitux)FDA Link
10/2023 - 10/2021
2ORALIT (ORS)IBA
10/2023 - 01/2023
2GemcitabineFDA Link
09/2023 - 01/2021
2aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA
01/2023 - 01/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2022 - 10/2015
2Uric Acid (Urate)IBA
01/2022 - 08/2019
2RNA (Ribonucleic Acid)IBA
10/2021 - 01/2020
2Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2021
2PhytochemicalsIBA
01/2020 - 01/2019
2AcidsIBA
12/2019 - 01/2019
2Therapeutic UsesIBA
12/2019 - 05/2010
2Lactic Acid (Lactate)FDA LinkGeneric
07/2019 - 09/2002
2Interleukin-10 (Interleukin 10)IBA
01/2019 - 07/2013
1MK 2206IBA
04/2024
1monodansylthiacadaverineIBA
02/2024
1Dopamine (Intropin)FDA LinkGeneric
02/2024
1TanninsIBA
02/2024
1RivaroxabanIBA
02/2024
1VaccinesIBA
01/2024
1Phosphotransferases (Kinase)IBA
01/2024
1tyrosine receptor (receptor, tyrosine)IBA
01/2024
1Immune Checkpoint ProteinsIBA
01/2024
1taxaneIBA
11/2023
1TamoxifenFDA LinkGeneric
11/2023
1Estrogen ReceptorsIBA
11/2023
1Nitrogen DioxideIBA
11/2023
1CaspasesIBA
11/2023
1SphingolipidsIBA
11/2023
1CeramidasesIBA
11/2023
1Immunoglobulin A (IgA)IBA
10/2023
1Interferon-gamma (Interferon, gamma)IBA
10/2023
1Long Noncoding RNAIBA
09/2023

Therapy/Procedure

14Therapeutics
02/2024 - 07/2013
13Endoscopes
03/2021 - 01/2009
6Drug Therapy (Chemotherapy)
04/2024 - 02/2020
6Immunotherapy
01/2024 - 10/2020
6Operative Time
07/2023 - 05/2012
4Thyroidectomy
10/2023 - 06/2014
4Radiotherapy
02/2015 - 10/2006
3Length of Stay
08/2023 - 10/2017
3Neck Dissection (Radical Neck Dissection)
01/2021 - 07/2014
2Lasers (Laser)
06/2023 - 01/2019
2Aftercare (After-Treatment)
09/2021 - 01/2015
2Gas Lasers
01/2019 - 01/2017
1Intravenous Injections
02/2024
1Critical Care (Surgical Intensive Care)
11/2023